Pure-Play Psychedelic Stocks Index Continued To Decline Wednesday For 4th Straight Day

This article tracks the performance of 15 of the 31 biopharmaceutical companies in the munKNEE Pure-Play Psychedelic Stocks Index that are involved in the research and development of psychedelic compounds to treat mental health issues.